September 16, 2019
Lundbeck will add Alder BioPharma's potential blockbuster migraine treatment, eptinezumab, to its pipeline ahead of patent expirations.
August 15, 2019
Drug sales are expected to top US$1 trillion by 2024, even though a number of patents are set to expire...
August 12, 2019
In response, Sandoz, a division of Novartis, said it will appeal the decision with the District Court of New Jersey.
August 4, 2019
Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
July 10, 2019
With Q2 2019 officially over, the Investing News Network shares a pharma market update on the biggest news and trends...
July 4, 2019
What are the biggest names in biotechnology? We count down the five top biotech stocks based on market cap and...
July 2, 2019
For investors looking for less volatility compared to stocks, here's an overview of the five largest biotechnology ETFs for consideration.